XML 28 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Outstanding
Common Stock
Value of Shares Held in Rabbi Trust at Cost
Deferred Compensation Obligation
Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2019 $ 1,708,143   $ 342 $ (4,735) $ 4,735 $ 1,035,450 $ 654,182 $ 18,169
Beginning balance (in shares) at Dec. 31, 2019   34,377,388            
Prior Period Reclassification Adjustment 1,553           1,553  
Net income 121,167           $ 121,167  
Other comprehensive income 22,526             22,526
Common Stock, Dividends, Per Share, Declared             $ 1.84  
Common dividend declared (60,878)           $ (60,878)  
Common stock issued for acquisition 0              
Proceeds from exercise of stock options, net of cash paid (197)         (197)    
Proceeds from exercise of stock options (in shares)   8,873            
Stock based compensation 4,123         4,123    
Restricted stock awards issued, net of awards surrendered (in shares)   47,182            
Restricted stock awards issued, net of awards surrendered (1,187)   1     (1,188)    
Stock Issued During Period, Shares, Other   32,249            
Stock Issued During Period, Value, Other 2,132   0     2,132    
Stock Repurchased During Period, Shares   (1,500,000)            
Stock Repurchased During Period, Value (95,091)   (15)     (95,076)    
Increase (Decrease) in Deferred Compensation       1,669 (1,669)      
Ending balance (in shares) at Dec. 31, 2020   32,965,692            
Ending balance at Dec. 31, 2020 1,702,685   328 (3,066) 3,066 945,638 716,024 40,695
Off-Balance Sheet, Credit Loss, Liability, Change in Method, Credit Loss Expense (Reversal) (1,000)              
Off-Balance Sheet, Credit Loss, Liability, Change in Method, Credit Loss Expense (Reversal), net of tax. 736              
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method (1,137)              
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method, net of tax. 817              
Net income 120,992           $ 120,992  
Other comprehensive income (38,512)             (38,512)
Common Stock, Dividends, Per Share, Declared             $ 1.92  
Common dividend declared (70,300)           $ (70,300)  
Common stock issued for acquisition 1,298,558   143     1,298,415    
Common stock issued for acquisition (in shares)   14,299,720            
Proceeds from exercise of stock options, net of cash paid (57)   0     (57)    
Proceeds from exercise of stock options (in shares)   4,744            
Stock based compensation 4,309         4,309    
Restricted stock awards issued, net of awards surrendered (in shares)   53,768            
Restricted stock awards issued, net of awards surrendered (1,249)   1     (1,250)    
Stock Issued During Period, Shares, Other   25,854            
Stock Issued During Period, Value, Other 2,023   0     2,023    
Increase (Decrease) in Deferred Compensation $ 0              
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits       (80) 80      
Ending balance (in shares) at Dec. 31, 2021 47,349,778 47,349,778            
Ending balance at Dec. 31, 2021 $ 3,018,449   472 (3,146) 3,146 2,249,078 766,716 2,183
Net income 263,813           $ 263,813  
Other comprehensive income (165,267)             (165,267)
Common Stock, Dividends, Per Share, Declared             $ 2.08  
Common dividend declared (96,087)           $ (96,087)  
Common stock issued for acquisition 0              
Stock based compensation 4,464         4,464    
Restricted stock awards issued, net of awards surrendered (in shares)   49,016            
Restricted stock awards issued, net of awards surrendered (1,084)   1     (1,085)    
Stock Issued During Period, Shares, Other   29,409            
Stock Issued During Period, Value, Other 2,359         2,359    
Stock Repurchased During Period, Shares   (1,786,965)            
Stock Repurchased During Period, Value (139,946)   (18)     (139,928)    
Increase (Decrease) in Deferred Compensation $ 0              
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits       (81) 81      
Ending balance (in shares) at Dec. 31, 2022 45,641,238 45,641,238            
Ending balance at Dec. 31, 2022 $ 2,886,701   $ 455 $ (3,227) $ 3,227 $ 2,114,888 $ 934,442 $ (163,084)